Additionally, JUNB is associated with the mechanistic Target of Rapamycin (mTOR) pathway in ALK+ ALCL but not in ALK− ALCL, as downregulation of JUNB expression is observed after rapamycin treatment [23]. This evidence concerns the gene JUNB and anaplastic large cell lymphoma.